New Products In Brief
This article was originally published in The Gray Sheet
Executive Summary
Berlin Heart’s Excor Pediatric ventricular assist device gains FDA humanitarian device exemption approval. Cerevast Therapeutics gains CE mark for Clotbust ER ultrasound device to treat ischemic strokes. More new products.
You may also be interested in...
Research In Brief
Recent data and study announcements in cardiac, neuro and diabetes.
News In Brief
IDS’ laser-based breast imaging system requires PMA
FDA Panel Unanimously Supports Berlin Heart's Excor Pediatric VAD
Following strong support from an FDA advisory panel, Berlin Heart is hoping for humanitarian device approval of its Excor Pediatric ventricular assist device within the next six months.